Table of Contents

2019-2024 Global Antihypertensive Drugs Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Antihypertensive Drugs Consumption 2014-2024
  • 2.1.2 Antihypertensive Drugs Consumption CAGR by Region
• 2.2 Antihypertensive Drugs Segment by Type
  • 2.2.1 Diuretic Antihypertensive
  • 2.2.2 Sympathetic Suppressant
  • 2.2.3 Renin-angiotensin System Inhibitor
  • 2.2.4 Calcium Antagonist Medicine
  • 2.2.5 vasodilator
• 2.3 Antihypertensive Drugs Consumption by Type
  • 2.3.1 Global Antihypertensive Drugs Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Antihypertensive Drugs Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Antihypertensive Drugs Sale Price by Type (2014-2019)
• 2.4 Antihypertensive Drugs Segment by Application
  • 2.4.1 The Old
  • 2.4.2 Pregnant Woman
  • 2.4.3 General Patient
• 2.5 Antihypertensive Drugs Consumption by Application
  • 2.5.1 Global Antihypertensive Drugs Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Antihypertensive Drugs Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Antihypertensive Drugs Sale Price by Application (2014-2019)

3 Global Antihypertensive Drugs by Players

• 3.1 Global Antihypertensive Drugs Sales Market Share by Players
  • 3.1.1 Global Antihypertensive Drugs Sales by Players (2017-2019)
  • 3.1.2 Global Antihypertensive Drugs Sales Market Share by Players (2017-2019)
• 3.2 Global Antihypertensive Drugs Revenue Market Share by Players
  • 3.2.1 Global Antihypertensive Drugs Revenue by Players (2017-2019)
  • 3.2.2 Global Antihypertensive Drugs Revenue Market Share by Players (2017-2019)
• 3.3 Global Antihypertensive Drugs Sale Price by Players
• 3.4 Global Antihypertensive Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Antihypertensive Drugs Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Antihypertensive Drugs Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Antihypertensive Drugs by Regions

• 4.1 Antihypertensive Drugs by Regions
  • 4.1.1 Global Antihypertensive Drugs Consumption by Regions
  • 4.1.2 Global Antihypertensive Drugs Value by Regions
• 4.2 Americas Antihypertensive Drugs Consumption Growth
• 4.3 APAC Antihypertensive Drugs Consumption Growth
• 4.4 Europe Antihypertensive Drugs Consumption Growth
• 4.5 Middle East & Africa Antihypertensive Drugs Consumption Growth

5 Americas

• 5.1 Americas Antihypertensive Drugs Consumption by Countries
  • 5.1.1 Americas Antihypertensive Drugs Consumption by Countries (2014-2019)
  • 5.1.2 Americas Antihypertensive Drugs Value by Countries (2014-2019)
• 5.2 Americas Antihypertensive Drugs Consumption by Type
• 5.3 Americas Antihypertensive Drugs Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Antihypertensive Drugs Consumption by Countries
  • 6.1.1 APAC Antihypertensive Drugs Consumption by Countries (2014-2019)
  • 6.1.2 APAC Antihypertensive Drugs Value by Countries (2014-2019)
• 6.2 APAC Antihypertensive Drugs Consumption by Type
• 6.3 APAC Antihypertensive Drugs Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Antihypertensive Drugs by Countries
  • 7.1.1 Europe Antihypertensive Drugs Consumption by Countries (2014-2019)
  • 7.1.2 Europe Antihypertensive Drugs Value by Countries (2014-2019)
• 7.2 Europe Antihypertensive Drugs Consumption by Type
• 7.3 Europe Antihypertensive Drugs Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Antihypertensive Drugs by Countries
  • 8.1.1 Middle East & Africa Antihypertensive Drugs Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Antihypertensive Drugs Value by Countries (2014-2019)
• 8.2 Middle East & Africa Antihypertensive Drugs Consumption by Type
• 8.3 Middle East & Africa Antihypertensive Drugs Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Antihypertensive Drugs Distributors
• 10.3 Antihypertensive Drugs Customer

11 Global Antihypertensive Drugs Market Forecast

• 11.1 Global Antihypertensive Drugs Consumption Forecast (2019-2024)
• 11.2 Global Antihypertensive Drugs Forecast by Regions
  • 11.2.1 Global Antihypertensive Drugs Forecast by Regions (2019-2024)
  • 11.2.2 Global Antihypertensive Drugs Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Antihypertensive Drugs Forecast by Type
• 11.8 Global Antihypertensive Drugs Forecast by Application

12 Key Players Analysis

• 12.1 Novartis
  • 12.1.1 Company Details
  • 12.1.2 Antihypertensive Drugs Product Offered
  • 12.1.3 Novartis Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Novartis News
• 12.2 Pfizer
  • 12.2.1 Company Details
  • 12.2.2 Antihypertensive Drugs Product Offered
  • 12.2.3 Pfizer Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Pfizer News
• 12.3 Johnson & Johnson
  • 12.3.1 Company Details
  • 12.3.2 Antihypertensive Drugs Product Offered
  • 12.3.3 Johnson & Johnson Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Johnson & Johnson News
• 12.4 Sanofi
  • 12.4.1 Company Details
  • 12.4.2 Antihypertensive Drugs Product Offered
  • 12.4.3 Sanofi Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Sanofi News
• 12.5 Lupin
  • 12.5.1 Company Details
  • 12.5.2 Antihypertensive Drugs Product Offered
  • 12.5.3 Lupin Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Lupin News
• 12.6 Ranbaxy Laboratories
  • 12.6.1 Company Details
  • 12.6.2 Antihypertensive Drugs Product Offered
  • 12.6.3 Ranbaxy Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Ranbaxy Laboratories News
• 12.7 Merck
  • 12.7.1 Company Details
  • 12.7.2 Antihypertensive Drugs Product Offered
  • 12.7.3 Merck Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Merck News
• 12.8 Astra Zeneca
  • 12.8.1 Company Details
  • 12.8.2 Antihypertensive Drugs Product Offered
  • 12.8.3 Astra Zeneca Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Astra Zeneca News
• 12.9 Daiichi Sankyo
  • 12.9.1 Company Details
  • 12.9.2 Antihypertensive Drugs Product Offered
  • 12.9.3 Daiichi Sankyo Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Daiichi Sankyo News
• 12.10 Takeda
  • 12.10.1 Company Details
  • 12.10.2 Antihypertensive Drugs Product Offered
  • 12.10.3 Takeda Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Takeda News
• 12.11 Actelion
• 12.12 United Therapeutics

13 Research Findings and Conclusion

Antihypertensive drug is a kind of medicine that can control blood pressure and is used to treat hypertension.

According to this study, over the next five years the Antihypertensive Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antihypertensive Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Antihypertensive Drugs market by product type, application, key manufacturers and key regions and countries.

This study considers the Antihypertensive Drugs value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Diuretic Antihypertensive
Sympathetic Suppressant
Renin-angiotensin System Inhibitor
Calcium Antagonist Medicine
vasodilator
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
The Old
Pregnant Woman
General Patient

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
Astra Zeneca
Daiichi Sankyo
Takeda
Actelion
United Therapeutics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Antihypertensive Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Antihypertensive Drugs market by identifying its various subsegments.
Focuses on the key global Antihypertensive Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antihypertensive Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Antihypertensive Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.